Biotech and nanotech investing, and andrew pharmaceuticals stocks
InformedInvestors.com - Forums - Previous Informed Investors Forums
Informed Investors offers investors contact with public companies executives and industry experts. ... Biotech/Phase III Drug Stocks Virtual Forum. BioCryst Pharmaceuticals, Inc. Insmed Inc. ... Virtual Medical Devices Stocks Forum. Jay, Andrew. Aastrom Biosciences, Inc ...
http://www.informedinvestors.com/iif_forums/forums_index.cfm?Previous=True
The Wall Street Transcript Online
A unique and independent investment publication interviewing well known analysts, money managers and CEOs who recommend stocks, analyze market trends and rate management performance by sector. ... in-depth (13,400 words) Analyst Roundtable, Andrew Forman, Director at UBS Warburg, Ian Sanderson, Managing ... 2) Specialty Pharmaceuticals Stocks - In an-depth (4,500 words) Analyst ...
http://www.twst.com/info/info190.htm
Inpharmatica secures ADME service agreement with Ionix Pharmaceuticals
... BioJob Career. BioTechnologies. BioExecutive. BioEquities/Stocks. BioDrug Discovery. BioJournal. BioAnalysis ... For information about Ionix Pharmaceuticals:Andrew Sandham+ 44 1223 433 733 ...
http://www.bioportfolio.com/news/ala_inpharmatica_1.htm
Quote.com: Stocks & News: News Center
Get the latest news and corporate press releases from Wall Street and the financial and global markets. ... Guilford Pharmaceuticals Announces Resignation of Andrew R. Jordan, Chief ... GUILFORD PHARMACEUTICALS INC FILES FORM SC 13G (GLFD ... Guilford Pharmaceuticals to Announce First Quarter 2004 ...
http://www.finance.lycos.com/qc/news/headlines.aspx?symbols=GLFD
Andrew Leckey's Q&A
... I'm interested in investing in pharmaceuticals. What's your opinion ... All drug stocks were hurt recently when ... different categories," explained Andrew Clark, senior research analyst ...
http://www.thebullandbear.com/articles/2003/0503-leckeyqa3.html
Andrew Leckey's Q & A
Andrew Leckey's. Q & A. Q. What's your opinion of AT&T Corp. stock, both short and long-term? L.G., Indianapolis, IN. A. ... adept at picking European stocks and balancing overseas risks with domestic stocks ... Warner-Lambert acquired AGOURON Pharmaceuticals, which focuses its research ...
http://www.thebullandbear.com/articles/1999/1099-q-a.html
MSN Money - GLFD Key Developments: Investing
Key developments for provides key devlopments about the company. ... Power Searches. Top Rated Stocks. Related Links ... May 03, 2004. Guilford Pharmaceuticals Inc. announced that Andrew R. Jordan, Executive Vice President, Finance and ...
http://news.moneycentral.msn.com/ticker/sigdev.asp?Symbol=GLFD
Interview with Andrew Forman, UBS Warburg: TWST
... TWST: Andrew, given how well the stocks have done, in general, what s the upside ... Remember, with few exceptions, specialty pharmaceuticals business models are predicated on making ...
http://www.twst.com/notes/articles/kaz450a.html
Search Google
Search MSN
Search Yahoo
101investor.com Super Directory | Index |
best biotech stocks | the genetic engineering debate | list of biotech companies in california | nanotechnology conference | emerging medical companies with stock options | nanotechnology computer systems | genetic engineering cons | forbes nanotechnology
|
copyright (c) 2004 101investor.com
contact: admin @ 101investor.com
|